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Abstract
The generation of appropriate adaptive immune responses relies critically on dendritic cells, about which relatively little is
known in chickens, a vital livestock species, in comparison with man and mouse. We cloned and sequenced chicken DEC205
cDNA and used this knowledge to produce quantitative PCR assays and monoclonal antibodies to study expression of
DEC205 as well as CD83. The gene structure of DEC205 was identical to those of other species. Transcripts of both genes
were found at higher levels in lymphoid tissues and the expression of DEC205 in normal birds had a characteristic
distribution in the primary lymphoid organs. In spleen, DEC205 was seen on cells ideally located to trap antigen. In thymus it
was found on cells thought to participate in the education of T cells, and in the bursa on cells that may be involved in
presentation of antigen to B cells and regulation of B cell migration. The expression of DEC205 on cells other than antigen
presenting cells (APC) is also described. Isolated splenocytes strongly expressing DEC205 but not the KUL01 antigen have
morphology similar to mammalian dendritic cells and the distinct expression of DEC205 within the avian-specific Bursa of
Fabricius alludes to a unique function in this organ of B cell diversification.
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Introduction
Specialized APC sample the environment and ensure that
appropriate antigen-specific adaptive immune responses protect
an animal from danger, by activation and expansion of specific
effectors from a randomly generated anticipatory repertoire, a
function common to all jawed vertebrates. The converse
generation of anergy by tolerance or clonal deletion is essential
to prevent the recognition of self and is also driven by antigen
presentation.
The generation of de novo adaptive responses, including
responses to vaccines, is primarily elicited by dendritic cells
(DC), specialist leucocytes adapted for antigen capture, processing
and presentation to T lymphocytes [1]. Knowledge of these cells in
a target species is therefore crucial in finding the most effective
means of vaccination. Chickens are the largest source of animal
protein worldwide, and their protection from numerous pathogens
is mostly achieved by vaccination. However our understanding of
DC in this species is limited (reviewed in [2] [3]). The generation
of bone-marrow derived DC (BM-DC) has recently been described
[4] and the cloning of a number of DC-related genes has
facilitated the transcriptional analysis of BM-DC responses [3,5,6].
Although chickens have a different repertoire of immune receptor
molecules, with cytokines, chemokines and TLR differing from
mammalian counterparts, in vitro responses of chicken BM-DC
essentially reflect those described in biomedical species. Notwith-
standing these observations, few tools have been developed for the
study of chicken DC in vivo, the sole report being of the generation
of antibodies to CD83 [7] in which the authors reported a unique
phenotype and distribution of a CD83 expressing cell.
That avian lymphoid tissues differ structurally from those of
mammals has been well documented (reviewed in [8]). In common
with most non-aquatic birds chickens lack lymph nodes, the
primary site in mammals of DC-T cell interaction, though they
possess less organised lymphoid nodules [9] and lymphoid
aggregates in other tissues. The avian spleen differs from that of
mammals [10] in both architecture and function [11]. Monoclonal
antibodies have been used to define non-lymphoid cells in the
chicken spleen, though lack of molecular characterization of the
binding specificities of these reagents limits interpretation [12].
The Bursa of Fabricius is the primary site of B cell development
[13] where B cell diversity is generated in avian species (reviewed
by Ratcliffe [14]). A pleated epithelium is packed with underlying
follicles, full of developing B cells, divided into cortical and
medullary regions by a separating layer of other cells. Dispersed
amongst the B cells is a minor population of bursal secretory
dendritic cells (BSDC), first described by Olah [15].
While the thymus of chickens is remarkable in possessing 14
lobes, its micro-architecture and function appear to be grossly
similar to that of mammals. Education of T cells by self-
recognition is presumed to take place as in mammals [16] and
defects in this process produce autoimmunity [17].
DEC205 is a C-type lectin endocytic receptor of the mannose
receptor family, first cloned in mouse [18] and named because of
its molecular weight and principal distribution in mice on DC and
Thymic epithelial cells. It is known to enhance antigen presenta-
tion via MHCII+ve lysosomal compartments [19], to be involved in
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the cross-presentation of antigen [20] and the recognition of
apoptotic and necrotic self [21]. We surmised that the cloning of
chicken DEC205, and production of antibodies to study it’s
expression, would afford a valuable tool to further the under-
standing of antigen presentation by cells in the uniquely adapted
immune organs of chickens. We also generated CD83 recognising
antibodies, adding to the repertoire of available DC reagents, and
allowing a comparison of the expression of this reported marker of
mature (antigen presenting) DC [22] with the expression of
DEC205, a molecule involved in antigen sampling.
Investigations with the DEC205 antibodies allowed us to study
the expression of the molecule within bursa, spleen and thymus
and on isolated splenocytes, including those enriched for adherent
cells.
Results
Sequence of the chicken DEC205 gene
Human and mouse DEC205 peptide sequences were used to
search all available chicken EST databases. Three contigs were
constructed, with sequence similarity spanning 83% of the human
gene and including the 59 end of the coding sequence. PCR using
primers based on these sequences (Figure S1 and Table S2) was
used to amplify the whole cDNA sequence, from Line 0 spleen
cDNA and Light Sussex bursa cDNA libraries, including the
sequences in the gaps between contigs. Several strategies for
cloning the predicted 59 signal-peptide exon, present in a single
EST, from cDNA libraries were unsuccessful. To confirm the
contiguity of the 59 exon, sequence was obtained from a chicken
genomic BAC clone by primer walking from the 59 end of the
sequence successfully amplified by PCR (Figure S2 and Table S2).
This yielded the expected exon sequence after crossing an intron
with canonical splice sites.
The full length coding sequence determined from cDNA and
BAC sequences was submitted to the EMBL database (Accession
number AJ574899). This provided the primary evidence for the
gene annotation in Ensembl (ENSGALG00000011153) and in
REFSEQ (NM_001037836). The ENSEMBL annotation includes
an additional transcript (ENSGALT00000038329) which has a
single codon insertion at the splice acceptor site preceding exon 17
and a three codon insertion at the beginning of exon 30. The
former results from use of the first instead of the second ag in the
sequence agcagGTAGCA at the splice acceptor site. The latter
uses a non-canonical splice acceptor. Since there is no cDNA
evidence for either, this variant transcript is probably an artifact of
the ENSEMBL pipeline and is unlikely to exist.
The exon structure of the chicken gene is shown in Figure 1,
with its relationship to the conserved protein domains. It is
essentially identical to the human DEC205 gene structure, with
identical intron phases and only small differences in exon lengths.
The chicken introns are shorter than the human equivalents, as is
the case for most chicken genes. In the mouse, the one long
transcript, ENSMUST00000028362, for which there is effective
supporting evidence also has the identical gene structure.
Examination of the gene in its genomic context revealed a large
upstream region with the order of many orthologous genes
conserved in the human and chicken genomes, at least 1.6 million
nucleotides in the chicken and 4 million in the human. This region
of conserved gene order confirms that this is the chicken
orthologue of the human LY75 (DEC205, CD205) gene. There
is a break in conservation of gene order downstream of the chicken
gene.
Transcription of DEC205 and CD83 in tissues
Quantitative PCR measurements of transcript levels of DEC205
and CD83 genes are shown in Figure 2. Whilst there was
constitutive expression in a range of tissues, there were significant
differences in the level of either transcript (Anova; DEC205,
P,0.002; CD83, P,0.0002). The transcript level of either gene in
spleen and thymus was significantly higher than in all other tissues
(Spleen: DEC205, P,0.01 for all tissues except bursa, skin and
muscle; CD83, P,0.01 for all tissues except bursa. Thymus:
DEC205, P,0.01 for all tissues; CD83, P,0.01 for all tissues
except bursa).
Monoclonal antibodies recognising chicken DEC205 and
CD83
Taylor et al. [23,24] showed that ligand binding by the human
macrophage mannose receptor, MRC1, depended on CTLD
domains 4–6. We surmised that the equivalent domains of the
DEC205 protein might likewise be responsible for ligand binding
and might therefore be accessible to antibody in the native form of
the molecule. Therefore we expressed these three domains of
chicken DEC205 in a secreted Ig fusion protein (Figure S3), to
provide the immunogen for raising monoclonal antibodies that
might recognise chicken DEC205. From five cloned hybridomas
selected after screening by ELISA, immunohistological staining
and flow cytometry, two, IAH F877:FG9 (IgG1) and F877:AD6
(IgG2b) were chosen for further studies. No differences were seen
between the patterns of staining with these two antibodies in
innunohistochemistry or flow cytometry applications. Immuno-
precipitates of unlabelled splenocyte proteins and of proteins
precipitated from adherent cells after radiolabelling in the
presence or absence of LPS were analysed by SDS PAGE (Figure
S5). The antibody specifically precipitated a band co-migrating
with the 260 kDa marker that was absent with other antibodies.
The coding sequence of chicken CD83 was identified from
similar searches of EST databases as previously described [7]. The
extracellular domain was expressed in the form of a soluble fusion
Figure 1. Structure of the chicken DEC205 gene. At the top, those parts of the 35 exons containing coding sequence are drawn to scale and
labelled with their lengths in nucleotide residues. Introns are not to scale although their lengths relative to each other are approximately as drawn.
The protein domain structure is shown below using shaded rectangles drawn to scale, with annotations: S, signal sequence; FNII, fibronectin type II;
CTLD, C-type lectin like domain; TM, transmembrane region; Cyto, cytoplasmic region. Dotted lines connect the ends of domains to the encoding
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protein with human IgG1 Fc (Figure S4) and used to raise
monoclonal antibodies. Six hybridomas secreting antibody specif-
ically recognising the CD83 part of the fusion protein in ELISA
assays were cloned. These were further tested by flow cytometry
for binding to chicken splenocytes, and the antibody IAH
F890:GE8 (IgG2a) was selected for further use. This was shown
to react with the native chicken CD83 molecule expressed on the
surface of transfected COS cells (Figure S6).
Expression of DEC205 and CD83 in tissues
Localization of cells expressing DEC205 in normal chicken
spleen is shown in Figure 3. DEC205+ve cells were principally
found in the ellipsoids and immediately adjacent to arterioles, at
the centre of the B cell rich (Bu1+ve) peri-ellipsoid lymphoid sheath
(PELS) and the T cell rich (CD4+ve) peri-arteriolar lymphoid
sheath (PALS) respectively. In contrast, macrophages (KUL01+ve)
were found in areas delineating the borders of PELS. We did not
find consistent staining with the CD83 antibody.
In the spleens of birds infected with MDV (Marek’s Disease
Virus), germinal centres (GC) were seen to form adjacent to
arteries but within the T cell rich PALS (Figure 4). Cells expressing
DEC205 were widespread within the PALS but very few were seen
within the CG. CD83+ve cells were found in discrete aggregates
within the PALS but not within GC.
In the thymus DEC205 was seen to be expressed on cells with a
reticular phenotype within both the cortex and medulla (Figure 5).
Small aggregates of CD83+ve cells were seen in the medulla,
immediately adjacent to the cortico-medullary boundary.
In the bursa, a continuous layer of cells at the cortico-medullary
boundary strongly expressed DEC205 (Figure 6). In addition,
discrete DEC205+ve cells with dendritic morphology were seen
evenly distributed in both cortex and medulla of the bursal
follicles. We did not find consistent staining with the CD83
antibody in the bursa.
Figure 2. Transcript levels of DEC205 and CD83 genes in tissues. The vertical scale represents transcript levels relative to the reference 28S
RNA on a logarithmic (base 2) scale. Bars indicate the levels in each of the tissues indicated below the horizontal axis. Error bars indicate the standard
error of three assays carried out on RNA preparations from tissue samples from different birds.
doi:10.1371/journal.pone.0051799.g002
Figure 3. Localisation of cells expressing DEC205 in normal
chicken spleen. The four panels show a set of serial sections of the
same area from the normal spleen of a juvenile bird, stained with
antibodies recognising the indicated molecules. Bu-1 reveals B cells and
CD4 a subset of T cells. KUL01 is a marker for monocyte/macrophage
lineage cells. DEC205 is detected using the antibody FG9. The dotted
curves indicate the approximate outlines of the same peri-ellipsoid
lymphocyte sheaths (pe) in each section. Other labelled features are
ellipsoid (e), aterioles (a) and peri-arteriolar lymphocyte sheath (pa) [12].
doi:10.1371/journal.pone.0051799.g003
Figure 4. DEC205 and CD83 expressing cells in the spleen of a
MDV infected bird. The four panels show a set of serial sections of
the same area from the spleen of a juvenile bird five days after infection
with Marek’s disease virus. The sections are stained with antibodies
recognising the indicated molecules. Bu-1 revealing B cells and CD4 &
CD8 revealing T cells. DEC205 is detected using the antibody FG9 and
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Cells in non-lymphoid tissues were also seen to express DEC205
(Figure S7). In many cases the distribution of these was consistent
with expression by endothelial cells.
Expression of DEC205 on ex vivo splenocytes
The population of cells isolated in adherent spleen cell
preparations were highly depleted of lymphocytes (data not
shown). Double staining of LPS-stimulated cells for DEC205
and the KUL01 antigen revealed two phenotypes (Figure 7),
DEC205+ve, KUL01+ve and DEC205+ve KUL012ve. Differential
interference contrast imaging showed the KUL01+ve cells to be
macrophage-like, with condensed cytoplasm. The KUL012ve cells
had more expanded cytoplasm with the appearance of veiled cells
[25]. DEC205 expression was upregulated following LPS stimu-
lation, particularly with respect to a vesicular compartment that
may represent early endosomes (Figure 8A,B). CD83 expression
appeared to be entirely vesicular in the unstimulated condition but
rapidly increased on the cell surface following stimulation. Staining
of stimulated and unstimulated cells for MHC class II (MHCII)
and DEC205 is consistent with the translocation of MHC II from
a lysosomal compartment to the cell surface accompanied by an
up-regulation of DEC205 (Figure 9).
Fresh preparations of adherent cells were incubated with
fluorescent microbeads to detect phagocytic activity, and then
stained with either DEC205 or KUL01 antibody (Figure 10).
Double staining of the fresh cells showed that DEC205 expression
on KUL01+ve cells was much lower than on KUL012ve cells in
Figure 5. DEC205 and CD83 expressing cells in normal thymus.
The four panels show a set of serial sections of the same area from the
thymus of a juvenile bird. The sections are stained with antibodies
recognising the indicated molecules. Bu-1 revealing B cells and CD4 &
CD8 revealing T cells. DEC205 is detected using the antibody FG9 and
CD83 using GE8. Cortical (c) and medullary (m) areas of a thymic lobe
are labelled.
doi:10.1371/journal.pone.0051799.g005
Figure 6. DEC205 expression in the juvenile bursa. The left panel
shows a lower magnification of a section of bursal tissue stained with
the DEC205 antibody FG9. The right panel shows a higher power view
of the region of the same section indicated by the dashed lines. Two
blood vessels in the interfolicular space are labelled (v). The cortex (c)
and medulla (m) of the bursal follicle are also indicated. The arrowhead
marks the layer of stained cells at the cortico-medullary boundary.
doi:10.1371/journal.pone.0051799.g006
Figure 7. Distinct populations of adherent splenocytes ex-
pressing DEC205. Adherent spleen cells were stimulated with LPS for
three hours, then permeabilised and stained with FG9 anti DEC205
antibody (green, Alexa Fluor 488) and KUL01 monocyte/macrophage
marker (red, Alexa Fluor 568). Nuclei were stained with DAPI (blue). The
left panel shows the pseudocolour image from the confocal micro-
scope, and the right panel shows a differential interference contrast
image of the same cells. KUL01 positive cells with rounded morphology
are indicated with large arrowheads and KUL01 negative cells with
flattened and extended morphology are indicated with double arrows.
doi:10.1371/journal.pone.0051799.g007
Figure 8. Increased expression of DEC205 on LPS stimulation
of adherent spleen cells. The upper two panels show images from
two chambers of the same slide, one having been incubated with LPS
for one hour (A) and one without (B) The cells were stained with FG9
anti DEC205 antibody (green) and GE8 anti CD83 antibody (red). Nuclei
were stained with DAPI (blue). Staining, confocal camera settings and
image processing were identical for both images. Surface staining of
ungated (C) or cells gated for CD11c expression (D) following
stimulation with LPS or CD40 ligand fusion protein are also shown.
doi:10.1371/journal.pone.0051799.g008
Chicken DEC205
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this preparation. Consequently the DEC205 staining of KUL01+ve
cells that had ingested brightly fluorescent beads was hard to
discern. However, there were brightly stained DEC205 positive
cells that were devoid of beads (middle) while all KUL01+ve cells
had ingested beads (bottom). Thus the DEC205+veKUL012ve cells
were not phagocytic, while the DEC205lo KUL01+ve cells had
actively phagocytosed fluorescent microbeads.
Expression of DEC205 on ex-vivo leucocytes
DEC205 was expressed at very low levels on B cells and T cell
subsets of leucocytes (Figure 11), although this was less evident in
the spleen. Strong expression of DEC205 was seen on cells also
decorated with CD83, to a level that was not apparent on
KUL01+ or CD11c+ cells. The effect of LPS and CD40 ligand
stimulation was also demonstrated by cytometry (Figure 8C,D)
Discussion
We found that chicken DEC205 has a highly conserved gene
structure and sequence with its human orthologue (EMBL
AJ574899 and Figure 1). Sequence identity of 51% to human
and 48% to mouse is also high for genes with immune functions
from these phylogenetically distant species, suggesting selection
pressure for conservation of function. The cytosolic domain of
mouse DEC205 has two motifs critical to its specialist function on
DC [19]. A coated pit localisation sequence FSSVRY is conserved
between many species [26] and is essential for endocytosis, its
removal ablating antigen uptake. The significance of a change of
arginine to histidine in the corresponding chicken sequence is not
clear, although this is a statistically favored substitution [27],
maintaining the basic character of the replaced residue. A distal
triad of acidic amino acids (EDE or DDE) is also conserved and
may be critical to the targeting of antigen to late endosomes [28].
Quantitative RT-PCR indicated that the tissues most closely
associated with immune responses had the highest levels of
transcripts for DEC205 and CD83 (Figure 2), varying from a base
level of transcription across a range of tissues. In the mouse,
DEC205 transcription was only seen in vivo in the lymph nodes and
thymus [29]. However, this was probably a consequence of the
limited sensitivity of the PCR technique employed, as the
monoclonal antibody NLDC-145, on which this work was based,
identified individual positive cells in peripheral locations, including
Langerhans cells in the skin [30]. We would surmise that the more
sensitive qRT-PCR used in the present study is reporting both
high levels of transcription in relatively rare cells (e.g. Langerhans
cells of the skin) and the lower levels of expression we have
demonstrated on other cell types (Figure 11). In contrast to our
findings a previous study failed to detect any CD83 transcription
in chicken skin or brain [7].
The immunization of mice by a DNA-DNA-protein prime-
boost strategy facilitated the rapid production of monoclonal
antibodies with specificities for DEC205 and CD83 that we then
used to study the expression of these molecules in vivo and ex vivo.
Figure 9. Surface mobilisation of MHC class II upon LPS
activation of DEC205-expressing adherent cells. Adherent spleen
cells were stimulated with LPS for three hours, permeabilised, and
stained with AD6 anti-DEC205 antibody (green) and 2G11 anti MHC
class II antibody (red). Nuclei were revealed with DAPI (blue). The inset
shows an image of an unstimulated cell stained in the same way.
doi:10.1371/journal.pone.0051799.g009
Figure 10. Adherent cells expressing DEC205 are non-pahgo-
cytic. The top pair of panels shows confocal images of fresh adherent
cells stained with both DEC205 and KUL01 antibodies. The left hand
image reveals low level expression of DEC205 on the KUL01 positive
cells. The same cell preparation was incubated with fluorescent
microbeads for three hours and then fixed and permeablised before
staining with either DEC205 antibody FG9 (middle) or KUL01 (bottom),
and examination by confocal microscopy. The pseudocoloured
fluorescence images are on the left with beads in yellow and antibody
staining in red. At the right are the corresponding differential
interference contrast images. Red arrows point to cells that are strongly
stained with DEC205 antibody but have no internalised fluorescent
beads. Yellow arrows point to cells that have internalised fluorescent
beads. The white arrow points to a cell that is not stained with KUL01.
doi:10.1371/journal.pone.0051799.g010
Chicken DEC205
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The distribution of DEC205+ve cells in normal spleen showed
clear relationships with other immune cells and with splenic
architecture (Figure 3). Particularly, DEC205+ve cells were found
in the ellipsoids and the immediate peri-arteriolar area, but not
concentrated in the PALS or PELS. This is consistent with the
distribution of ellipsoid-associated non-lymphoid cells (ENAC)
[12] and ellipsoid-associated cells (EAC) [31] previously described.
The location of DEC205+ve and CD83+ve cells during the process
of germinal centre formation was studied following infection of
birds with MDV (Figure 4). In this case strong expression of
DEC205 on cells adjacent to arterioles was accompanied by an
increase in the numbers of DEC205+ve cells scattered throughout
the PALS. Few DEC205+ve cells were seen in germinal centres.
The ontogeny of the immune response in birds is incompletely
understood, although these findings are consistent with the
migration of antigen bearing EAC from ellipsoids to PALS
demonstrated by other groups [31,32]. However, the constitutive
presence, in specific pathogen free (SPF) animals, of DEC205+ve
cells in the immediate peri-arteriolar area must now also be
considered. It may be that these cells had their origin in the
ellipsoids and migrated to the immediate peri-arteriolar position as
the result of an undefined antigenic stimulation. The more
plausible alternative is that as the central artery branches to form
the pencilliar capillaries, so the immediate peri-arteriolar com-
partment is anatomically contiguous with the expanded peri-
capilliary ellipsoids. Notwithstanding previous studies, the function
of cells within the centre of the PALS with the potential for antigen
uptake and presentation to T lymphocytes remains to be
elucidated.
In the present study foci of cells strongly expressing CD83 were
seen at the periphery of the T cell-rich PALS but not in fully
formed germinal centers following infection with MDV (Figure 4).
This is at variance with other work using polyclonal antibodies to
CD83 [7], which concluded that CD83+ve cells show a unique
association with B cell compartments of the chicken.
Expression of DEC205 on thymic epithelial cells [18] is known
to be involved in the clearance of apoptotic thymocytes [33], with
areas of the C-type lectin domains recognising ligands associated
with apoptosis and necrosis [21]. Expression in chicken thymus
(Figure 5) suggests that this function is maintained. Expression of
CD83 in chicken thymus is restricted to foci of cells within the
medulla but adjacent to the cortico-medullary junction. Although
these appear similar to the DC foci induced around Hassall’s
Corpuscles, that are responsible for the induction of
CD4+veCD25+ve regulatory T cells in human thymic medulla
[34], further work is required to confirm this relationship.
Expression of DEC205 in the bursa is more complex (Figure 6).
Its distribution closely resembles that of vimentin expressing
BSDC previously described by Olah and Glick [35–37]. A minor
population of DEC205+ve cells with dendritic morphology are
dispersed throughout both medulla and cortex. In contrast to this
scattered distribution, at the cortico-medullary boundary there is a
continuous layer of DEC205+ve cells. A role for BSDC in driving
gene conversion and the selective expansion of the B cell
compartment, has been proposed [38]. The relevance of the
separation of cortex and medulla by cells expressing DEC205 is
unclear. It has been proposed that B cell migration from the cortex
to medulla might be induced by encountering gut antigens. While
the dispersed BSDC are ideally situated to initiate migration
between these compartments, the continuous layer at the
boundary could enable more stringent regulation of the process.
DEC 205 has been shown to be a receptor for apoptotic self [21]
and to be involved in the clearance of apoptotic thymocytes [33].
DEC205+ve cells in the bursa may have a similar role, as the
majority of bursal cells generated each day do not emigrate but die
in situ [39] by the mechanism of apoptosis [40].
The analysis of ex-vivo avian DC has not hitherto been reported,
although DC induced by cytokines in-vitro have been studied [3–5].
We used short term adherence to enrich for a population of
splenocytes that were depleted of lymphocytes but had the
morphological characteristics of DC and macrophage. Without
prior stimulation only cells that expressed the KUL01 antigen
were able to phagocytose microbeads, while cells expressing high
levels of DEC205 were not phagocytic. Although both cell types
could upregulate DEC205 expression following LPS stimulation,
the KUL01 antigen remained restricted to macrophage–like cells
while DEC205+ve cells retained classical DC morphology. These
cells were also able to mobilise MHC class II to the cell surface.
We propose a working definition of the unstimulated ex-vivo avian
non-phagocytic DC as being DEC205+ve, KUL012ve, and
expressing MHC class II in a vesicular compartment.
Figure 11. DEC205 expression on leucocyte subsets. Spleno-
cytes, bursal cells and thymocytes recovered by enzymatic digestion
were stained with DEC205 antibody and antibodies recognising each of
the indicated antigens. The figure shows histograms of the DEC205
antibody fluorescence for cells gated for positive expression of the
markers indicated at the left. Controls are the staining of appropriate
subclass control antibodies on cells gated for the same markers.
doi:10.1371/journal.pone.0051799.g011
Chicken DEC205
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Low level expression of DEC205 on leucocytes other than DC
was first described on mouse lymph node B cells [41] and has
subsequently been shown on human B and T lymphocytes, NK
cells and macrophages [42]. Here we report low-level expression
on chicken CD4+ve, CD8+ve and cd T lymphocytes, B lymphocytes
and macrophages, the relative expression being dependent on the
tissue origin of the cells. The function of DEC205 on these cells
remains a matter of speculation.
In summary we have sequenced chicken DEC205, and
produced monoclonal antibodies with specificity for DEC205
and CD83. We have identified the populations of cells expressing
DEC205 in the major immune organs and determined expression
on ex-vivo cells, allowing us to propose a phenotypic definition of
avian DCs, as DEC205+ve and KUL012ve that now needs to be
expanded and tested in functional studies. The many similarities
with mammalian species are balanced by the differing require-
ments of the unique architecture of the avian immune system. In
particular, the identification of a layer of DEC205 expressing cells
at the cortico-medullary junction of the bursa points to a novel




All animal procedures were performed in accordance with the
UK Animals (Scientific Procedures) Act 1986 [43]. This study was
approved by the Pirbright Institute Ethical Review Panel and the
UK Home Office under project licence 30/2683.
Experimental animals
RPRL (Regional Poultry Research Laboratory, East Lansing,
MI.) Line 6 and Line 7 birds were obtained from the Compton
specific pathogen free breeding facility, from parents negative for
antibodies to specified pathogens, and were kept in controlled-
environment isolation rooms with food and water provided ad
libitum.
For DC and macrophage preparations, spleens were collected,
from Line 6 or Line 7 birds between 2 and 10 weeks old, into
sterile PBS on ice. For RNA preparations, tissue sections
(approximately 50 mg) were collected into RNA Later stabiliza-
tion fluid (Ambion, UK).
Two week old line 7 birds were infected with Marek’s disease
virus (MDV) strain RB1B, by administering 2.5 mg infective dust
by the intra-tracheal route [44]. Tissue samples from infected and
control birds, killed by cervical dislocation at various times after
infection, were used for cryosectioning and immunostaining.
Cell lines
Cell cultures were maintained in 5% CO2 at 37uC. COS-7 cells
[45] were grown in Dulbecco’s Modified Eagles Medium (DMEM)
(Invitrogen) with Glutamax, supplemented with 100 U/ml Peni-
cillin, 100 mg/ml streptomycin and 10% FCS. CHO cells [46]
[47] were grown in Ham’s F12 medium (Invitrogen) with 10%
FCS. Puromycin HCl (Enzo) was used at 20 mg/ml for selection
and at 15 mg/ml for maintenance of transfected CHO cells.
Antibodies
All antibodies used and their sources are described in Table S1.
PCR and sequencing of DEC205 gene
Bursa and spleen cDNA libraries were used for PCR-based
cloning of chicken cDNA. The bursa library was derived from
cDNA of 17-day embryonic bursa from Light Sussex chickens,
cloned in pCDM8 [48]. The spleen library was made from Line 0
chicken spleen cDNA, cloned in pcInX [49]. The vector pcInX is
pCINeo (Promega) with the XbaI-NotI fragment in the multiple
cloning site replaced by the XbaI-NotI fragment from pCDM8
(Invitrogen). It has two mutually inverted BstXI cloning sites. A
single BstXI site in the 39UTR of the Neo gene was removed by
cutting pcIneo with BstXI, treating with Klenow fragment of DNA
polymerase and re-ligating, before the modifications to the cloning
site [50]). Cloning of cDNA into this vector, or into pCDM8, was
carried out using the BstXI linker method described by Aruffo and
Seed [51].
PCR reactions were carried out using Taq polymerase
(Invitrogen) using the manufacturer’s recommended conditions
with 1.5 mM MgCl2, 0.2 mM dNTP (Promega), 1 mM primers
and 2.5 U of Taq polymerase (Invitrogen Life Technologies) in a
final volume of 50 ml with 50 ng of library plasmid DNA. PCR
was performed in a Biorad thermocycler as follows: 94uC for
2 min followed by 30 cycles of 94uC for 30 sec, 55uC for 30 sec,
72uC for 60–120 sec and a final 10 min extension at 72uC.
Amplified products were recovered from agarose gels (Qiagen
QIAquick gel extraction kit) and cloned into pGEM-T (Promega).
DNA prepared by Qiagen QIAprep spin miniprep kit was used for
sequencing.
A chicken BAC library (UK HGMP Resource Centre) was
screened by hybridisation with amplified and cloned DEC205
cDNA to identify 9 DEC205 positive BACS. One of these (103-
N18) was selected for sequence analysis, performed by primer
walking, from exon 2 to the 59 end of the coding sequence.
Sequencing was carried out directly on BAC DNA template
purified by Nucleobond BAC 100 maxiprep kit (Macherey-Nagel).
All DNA sequencing reactions were performed using the
Quickstart kit (Beckman Coulter) and were analysed using the
Beckman Coulter CEQ8000 DNA sequencer. Sequence data were
analysed using STADEN [52] and GCG (Wisconsin Package
Version 10.2, Genetics Computer Group, Madison, WI). Multiple
clones of PCR products were sequenced from each amplification
to obtain the consensus sequence and to identify clones free from
PCR errors.
Generation of monoclonal antibodies
An immunogen for production of DEC205 monoclonal
antibodies was produced by PCR amplification of cDNA encoding
C-type lectin-like domains (CTLD) 4 to 6 and insertion of the
amplified sequence in frame between a mouse CD8a signal
peptide and a human IgG1 constant region in which the hinge
cysteine residues had been replaced by serine residues [53], in the
vector pcIpac. This was accomplished by replacing the Nhe I – Bgl
II fragment, encoding the extracellular domain of chicken CD86,
of a construct, pKW06, expressing chicken CD86-human-IgG1Fc
(JRY and Kathryn Wright, unpublished). Primers used and the
confirmed junction sequences are described in the data (Figure
S3). After transfection of this construct into CHO cells using
Effectene (Qiagen) and selection with puromycin, transfected cells
were cloned by limiting dilution. Clones were tested for expression
using a sandwich ELISA for human IgG Fc using unlabelled and
HRP labelled goat anti-human IgG (Southern Biotech) as capture
and detection reagents. The fusion protein was purified from high
density culture (miniPERM, Sarstedt) supernatants by binding to
protein G columns (GE Biosciences, Hi-Trap), washing with PBS,
and elution with 0.1 M Glycine HCl, pH 2.7, according to the
manufacturer’s instructions for antibody purification. After dialysis
against PBS, the concentration of protein was estimated from
absorbance at 280 nm using a conversion factor (molar extinction
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coefficient, 162480) calculated from the peptide sequence (http://
web.expasy.org/protparam/).
While these manipulations were being conducted, mice were
immunized with two intramuscular injections of the fusion protein
expression plasmid at four week intervals. 100 mg of plasmid
(endotoxin free, Qiagen Endofree Plasmid Maxi Kit) was injected
intramuscularly in PBS. After a further four weeks, mice received a
final boost with intraperitoneal injection of 50 mg purified fusion
protein and were sacrificed four days later for preparation of
splenocytes which were fused with NS0 hybridoma partner cells
using established methods. Hybridoma supernatants were first
screened by ELISA for antibodies binding to fusion protein
immobilised with anti-human IgG, detected with HRP conjugated
goat anti-mouse IgG. Antibodies recognising the human Ig moiety
of the fusion protein were eliminated by a similar ELISA using a
control fusion protein containing the same human IgG1 sequence.
This was followed by flow cytometry using leucocytes prepared
from spleens by enzymatic digestion, and by immunostaining of
spleen, bursa and thymus sections using the VECTASTAIN Elite
ABC kit (Mouse IgG) (Vector laboratories) to detect binding of the
primary antibody.
For CD83 antibodies, a similar strategy was employed, using a
fusion protein in which the entire extracellular domain of chicken
CD83 was fused to the same human IgG1 Fc region. Details of the
primers used for amplification and introduction of restriction sites
for insertion into pKW06 are described in the supplementary data
(Figure S4). The cDNA was amplified from a ConA-stimulated
splenocyte library described previously [54]. COS-7 cells were
transfected using COSFectin (BioRad) following manufacturer’s
instructions. The fusion protein was purified from the supernatant
of COS-7 cells transfected with the constructed plasmid. For
detection and cloning of hybridomas, supernatants were screened
by sandwich ELISA for reactivity with the CD83 fusion protein
but not with a control Ig fusion protein.
Quantitation of DEC205 and CD83 transcripts
RNA was extracted from 30 mg samples of tissues using the
Nucleospin RNA II kit (Macherey-Nagel) according to the
manufacturer’s instructions. Homogenisation was performed using
a Mixer Mill MM300 (Retsch) and 3 mm stainless steel cone balls
(Retsch). The RNA isolation kit includes a DNase digestion step.
An additional proteinase K digestion was performed on heart,
muscle, skin and lung tissue to aid removal of contractile tissue,
connective tissue and collagen by addition of .6 mAU Proteinase
K (Qiagen) to the homogenised lysate and incubating at 55uC for
10 min.
Primers and probes for real-time quantitative PCR assay
(TaqmanH; Applied Biosystems, Foster City, California, USA)
were designed using Primer Express software (Applied Biosystems)
(Table S3). Probes were labelled with the fluorescent reporter dye
5-carboxyfluorescein (FAM) or 5-Yakima Yellow at the 59 end and
the quencher N,N,N,N9 tetramethyl-6-carboxyrhodamine
(TAMRA) at the 39 end. Assays were carried out using the
Superscript III platinum one-step qRT-PCR kit (Invitrogen).
Amplification and detection of specific products were carried out
with the 7500 Fast Real Time System (Applied Biosystems) with
the following cycle profile: 50uC for 5 min, 95uC for 2 min and
then 40 cycles of 95uC for 3 sec and 60uC for 30 sec. The
reference used for standardization was 28 s RNA. Primer and
probe sequences are presented in Table S3. Data analysis was
performed as described previously [55]. This yields transcript
levels in terms of a number log2R0, on a logarithmic (base 2) scale
where the value 0 represents the lowest detectable level of the
target mRNA in the sample with the most reference (28S) RNA,
and positive numbers represent the log2 of the fold increase over
that value in the test samples. The calculation includes a
correction for different levels of reference RNA in each sample.
Preparation of cell suspensions
Leucocytes were prepared from spleens by enzymatic digestion.
Spleens were washed in PBS and injected with a total of 3–4 ml of
2.2 mg/ml collagenase D (Boehringer Mannheim) in HBSS
(Sigma). After incubation at 37uC for 15 min in a shaking incubator,
cell suspensions were transferred to cold 10 mM EDTA in HBSS
without calcium (Sigma). Digestions were repeated until the spleen
tissue had completely disintegrated. The collected cell suspension
was filtered using a 100 mm cell strainer (BD Falcon), centrifuged at
2206g for 10 minutes at 4uC, resuspended in RPMI 1640 medium
with Glutamax (Invitrogen) supplemented with 5% FCS (Invitro-
gen). The suspensions were layered onto HistoPaque 1119 (Sigma),
centrifuged at 2000 rpm (4926g) for 20 min at 4uC, washed, and
resuspended at 56106/ml in RPMI 1640 containing 10% FCS.
Isolation of adherent cells
Either 56106 cells per well in 24-well plates containing a
13 mm glass coverslip, or 2.56106 cells per chamber of an 8-
chamber slide (Lab-Tek II), were incubated at 37uC for 2 h. The
non-adherent cell population was discarded and the adhered cells
subjected to a vigorous wash, then further cultured in RPMI 1640
containing 10% FCS. The adherent cell population was incubated
either alone or with addition of LPS (Sigma) at 200 ng/ml for
various times before fixation with 4% paraformaldehyde for
20 min. To observe phagocytosis, the enriched population was
incubated with 1 mM yellow-green carboxylate-modified micro-
spheres (Invitrogen) for 3 h, and observed using a confocal
microscope (Leica SP2 with 405-, 488-, and 568-nm lasers).
Immunostaining of tissue sections and adherent cell
populations
Tissues were collected into Cryosection Tissue Reservoirs
surrounded by OCT medium (Tissue Tek) and snap frozen in a
freezing bath of iso-pentane (2-methylbutane) on dry ice. Tissues
sections (6 mm) were cut using a cryostat (Leica CM1900) and
collected onto Polysine coated slides, air-dried overnight, and fixed
in ice cold 80% acetone, 20% methanol for 10 min. Slides were
stored in airtight containers at 270uC. Thawed sections were
incubated for 60 min with antibodies that were diluted to 5 mg/ml
in 0.4% (w/v) BSA in PBS. After washing with PBS, bound
antibodies were visualised using the Vectastain Elite ABC kit
(Vector Laboratories), and the Vector NovaRed substrate kit
(Vector Laboratories), according to the manufacturer’s instruc-
tions. Sections were counterstained with haematoxylin (Gill no. 3;
Sigma) and permanently mounted in Clearium (Surgipath).
For confocal imaging, adherent cells prepared as above were
permeabilised by incubation with 0.1% triton X-100 for 15 min,
after which non-specific reactivity was blocked by incubation with
5% (v/v) normal goat serum in PBS for 60 min. This was followed
by 60 min incubation with 5 mg/ml primary antibody in blocking
solution. Bound antibodies were detected using Alexa Fluor
labelled IgG class-specific antibodies (Table S1). Nuclei were
stained by incubation with 2 mg/ml DAPI (Sigma) for 10 min.
Sections were mounted in Vectashield (Vector Laboratories) and
analyzed using a confocal microscope as above.
Flow Cytometry
Cells were prepared as above. Immunofluorescent labeling was
carried out using DEC205 primary antibody (FG9) conjugated to
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Alexa Fluor 647 and CD83 antibody conjugated to Alexa Fluor 488
in combination with antibodies to KUL01, Bu-1, TCR-1, CD4,
CD11c or CD8b conjugated to PE. Doublets were excluded by
analysis of side scatter height and area parameters and dead cells
by LIVE/DEADH Fixable Aqua (Invitrogen).
For all labeling steps, cells (16106) were incubated for 15 min at
room temperature with appropriate dilutions of antibody in U
bottom 96-well microtitre plates with two washes between each
step. Normal mouse serum (5%) was used to block non-specific
binding of antibodies. PBS containing 1% BSA and 0.1% sodium
azide was used as dilution and washing buffer. Cells were analysed
using a FacsCalibur instrument (BD Becton Dickinson). FlowJo
software (TreeStar) was used to analyse flow cytometry data.
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